NeuroPace
Updates & Highlights
Kalkine · 30 days ago
Neuropace Inc (NASDAQ: NPCE) Share Price, NPCE Stock News, NPCE Share Price & Updates
TradingView · about 1 month ago
Enterprise value to EBIT forward of Neuropace, Inc. – NASDAQ:NPCE
TradingView · about 1 month ago
NeuroPace, Inc. expected to post a loss of 21 cents a share - Earnings Preview
Recent Openings
View all 1 jobs arrow_forwardAll Jobs
Culture & Mission
Benefits & Perks
Equity/Stock Options
Ownership in the company
Health Insurance
Medical, dental & vision
Remote Work
Work from anywhere flexibility
Learning Budget
Professional development
Generous PTO
Paid time off
401(k) Match
Retirement savings
Tech Stack
Core Values
Innovation
Pushing boundaries in AI/ML technology
Collaboration
Working together to achieve more
Excellence
Striving for the highest quality
Impact
Making a difference in the world
Office Locations
Team
Are you on the team at NeuroPace?
Claim this company page to verify ownership, edit details, and respond to applicants.
Claim this company arrow_forwardNews & Press
20 recentNeuropace Inc (NASDAQ: NPCE) Share Price, NPCE Stock News, NPCE Share Price & Updates
Neuropace Inc (NASDAQ: NPCE) Share Price, NPCE Stock News, NPCE Share Price & Updates
Kalkine · 30 days ago
Enterprise value to EBIT forward of Neuropace, Inc. – NASDAQ:NPCE
Enterprise value to EBIT forward of Neuropace, Inc. – NASDAQ:NPCE
TradingView · about 1 month ago
NeuroPace, Inc. expected to post a loss of 21 cents a share - Earnings Preview
NeuroPace, Inc. expected to post a loss of 21 cents a share - Earnings Preview
TradingView · about 1 month ago
Neuropace Inc (NPCE) Stock News Today
Neuropace Inc (NPCE) Stock News Today
TradingKey · about 1 month ago
Neuropace, Inc. (NPCE) Stock Analysis: A 45% Potential Upside Awaits Investors
Neuropace, Inc. (NPCE) Stock Analysis: A 45% Potential Upside Awaits Investors
DirectorsTalk Interviews · about 1 month ago
Earnings Preview: NeuroPace to Report Financial Results Post-market on August 11
Earnings Preview: NeuroPace to Report Financial Results Post-market on August 11
Moomoo · about 1 month ago
Neuropace Inc (NPCE) Earnings Forecast: Future EPS & Revenue Growth Estimates
Neuropace Inc (NPCE) Earnings Forecast: Future EPS & Revenue Growth Estimates
TradingKey · about 1 month ago
NeuroPace (NPCE) Expected to Release Earnings on Tuesday
NeuroPace (NPCE) Expected to Release Earnings on Tuesday
MarketBeat · about 1 month ago
NeuroPace, Inc. (NASDAQ:NPCE) Given Consensus Recommendation of "Moderate Buy" by Analysts
NeuroPace, Inc. (NASDAQ:NPCE) Given Consensus Recommendation of "Moderate Buy" by Analysts
MarketBeat · about 1 month ago
Neuropace, Inc. Revenue Breakdown – NASDAQ:NPCE
Neuropace, Inc. Revenue Breakdown – NASDAQ:NPCE
TradingView · about 1 month ago
H.C. Wainwright reiterates Buy on NeuroPace stock after FDA feedback
H.C. Wainwright reiterates Buy on NeuroPace stock after FDA feedback
Investing.com · about 1 month ago
NeuroPace drops as FDA denies bid to expand RNS System
NeuroPace drops as FDA denies bid to expand RNS System
Seeking Alpha · about 1 month ago
NeuroPace FDA Bid for Expanded Epilepsy Use Stalls as Agency Seeks More Data
NeuroPace FDA Bid for Expanded Epilepsy Use Stalls as Agency Seeks More Data
TradingView · about 1 month ago
NeuroPace FDA Bid for Expanded Epilepsy Use Stalls as Agency Seeks More Data
NeuroPace FDA Bid for Expanded Epilepsy Use Stalls as Agency Seeks More Data
TradingView · about 1 month ago
NeuroPace Receives FDA Guidance on PMA Supplement for Indication Expansion into Idiopathic Generalized Epilepsy
NeuroPace Receives FDA Guidance on PMA Supplement for Indication Expansion into Idiopathic Generalized Epilepsy
Business Wire · about 1 month ago
Neuropace Receives FDA Guidance On Pma Supplement For Indication Expansion Into Idiopathic Generalized Epilepsy
Neuropace Receives FDA Guidance On Pma Supplement For Indication Expansion Into Idiopathic Generalized Epilepsy
TradingView · about 1 month ago
Here's Why You Should Retain NeuroPace Stock in Your Portfolio for Now
Here's Why You Should Retain NeuroPace Stock in Your Portfolio for Now
Yahoo Finance · about 2 months ago
NeuroPace (NASDAQ:NPCE) Shares Down 5.8% - What's Next?
NeuroPace (NASDAQ:NPCE) Shares Down 5.8% - What's Next?
MarketBeat · about 2 months ago
NeuroPace (NPCE) Proxy filing Summary
NeuroPace (NPCE) Proxy filing Summary
Quartr · 2 months ago
NeuroPace, Inc. (NASDAQ:NPCE) Given Consensus Recommendation of "Moderate Buy" by Brokerages
NeuroPace, Inc. (NASDAQ:NPCE) Given Consensus Recommendation of "Moderate Buy" by Brokerages
MarketBeat · 2 months ago